Oncogene

Article	Citations
Identification of novel germline mutations in FUT7 and EXT1 linked with hereditary multiple exostoses	418
Increased antiandrogen enzalutamide sensitivity via altering prostate cancer stem cell traits through modulating the androgen receptor-mediated CDR1/circCDR1-AS/miR-1290/BMP4 signaling	265
Correction: Regulation of cancer stem cell activity by thyroid hormone receptor β	222
Correction to: Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential	170
Correction: S100A3 a partner protein regulating the stability/activity of RARα and PML-RARα in cellular models of breast/lung cancer and acute myeloid leukemia	157
Correction: DNA damage-induced translocation of mitochondrial factor HIGD1A into the nucleus regulates homologous recombination and radio/chemo-sensitivity	120
Correction: Tumour cell-derived exosomes endow mesenchymal stromal cells with tumour-promotion capabilities	116
A comprehensive analysis of LMO2 pathogenic regulatory profile during T-lineage development and leukemic transformation	113
PMM2 interacts with TRIM28 to recruit E2F4 and promote KIFC3-mediated tumor glycolysis and colorectal cancer progression	110
MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex	105
Retraction Note: Fermitin family member 2 promotes melanoma progression by enhancing the binding of p-α-Pix to Rac1 to activate the MAPK pathway	105
Hypoxia induces chemoresistance to proteasome inhibitors through orchestrating deSUMOylation and ubiquitination of SRC-3 in multiple myeloma	100
Retraction Note: CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells	91
Downregulation of HINFP induces senescence-associated secretory phenotype to promote metastasis in a non-cell-autonomous manner in bladder cancer	83
KDM6A alternative splicing induced by 25(OH)D inhibits breast cancer cell stemness through repressing TRAP1 transcription	81
GREB1 isoform 4 is specifically transcribed by MITF and required for melanoma proliferation	79
Gamma-glutamyltransferase 7 suppresses gastric cancer by cooperating with RAB7 to induce mitophagy	78
RAD51-mediated homologous recombination is a pro-tumour driver pathway	77
METTL3-mediated N6-methyladenosine modification of STAT5A promotes gastric cancer progression by regulating KLF4	76
Mapping the breast tumor microenvironment: proximity analysis reveals spatial relationships between macrophage subtypes and metastasis-initiating cancer cells	75
SOX10 deficiency-mediated LAMB3 upregulation determines the invasiveness of MAPKi-resistant melanoma	75
ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma	75
SCD5-dependent inhibition of SPARC secretion hampers metastatic spreading and favors host immunity in a TNBC murine model	73
RBMS3-loss impedes TRIM21-induced ubiquitination of ANGPT2 in an RNA-independent manner and drives sorafenib resistance in hepatocellular carcinoma	72
Notch signaling regulates a metabolic switch through inhibiting PGC-1α and mitochondrial biogenesis in dedifferentiated liposarcoma	70

Vimentin intermediate filaments orchestrate DNA nonhomologous end joining repair and lipolysis after DNA damage	68
RETRACTED ARTICLE: Targeting STING elicits GSDMD-dependent pyroptosis and boosts anti-tumor immunity in renal cell carcinoma	67
The hTERT-p50 homodimer inhibits PLEKHA7 expression to promote gastric cancer invasion and metastasis	67
Estrogen-related receptor alpha promotes thyroid tumor cell survival via a tumor subtype-specific regulation of target gene networks	67
tRF-33-P4R8YP9LON4VDP inhibits gastric cancer progression via modulating STAT3 signaling pathway in an AGO2-dependent manner	64
Spatiotemporal view of malignant histogenesis and macroevolution via formation of polyploid giant cancer cells	64
ALDH1A3 is the switch that determines the balance of ALDH+ and CD24−CD44+ cancer stem cells, EMT-MET, and glucose metabolism in breast cancer	63
BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer	62
LncRNA XIST regulates breast cancer stem cells by activating proinflammatory IL-6/STAT3 signaling	61
Deciphering glioma epitranscriptome: focus on RNA modifications	60
USP5 deubiquitinates and stabilizes IMPDH2, to promote hepatocellular carcinoma progression	60
RNA-sequencing predicts a role of androgen receptor and aldehyde dehydrogenase 1A1 in osteosarcoma lung metastases	59
RB loss determines selective resistance and novel vulnerabilities in ER-positive breast cancer models	59
Membrane flexibility induced by BST2 contributes to radioresistance in glioblastoma	59
RBM8A confers oxaliplatin resistance in gastric cancer by maintaining EGFR mRNA stability	56
AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors	55
PRSS23-eIF4E-c-Myc axis promotes gastric tumorigenesis and progression	55
Correction: HMGB1 correlates with angiogenesis and poor prognosis of perihilar cholangiocarcinoma via elevating VEGFR2 of vessel endothelium	55
Revealing the tumor suppressive sequence within KL1 domain of the hormone Klotho	54
STT3A-mediated viral N-glycosylation underlies the tumor selectivity of oncolytic virus M1	52
The protection of UCK2 protein stability by GART maintains pyrimidine salvage synthesis for HCC growth under glucose limitation	52
Crosstalk between endothelial progenitor cells and HCC through periostin/CCL2/CD36 supports formation of the pro-metastatic microenvironment in HCC	51
PIAS4 inhibition induces cell cycle arrest and exhibits a synergistic effect in combination with CDK4/6 inhibitor in breast cancer treatment	51
Extracellular vesicles of cancer cells induce FOXP3+ fibroblasts and facilitate tumor invasion via the Wnt3-β-catenin pathway	50
circPARPBP promotes cancer stemness and chemoresistance in triple-negative breast cancer through recruiting SRCAP complex to activate CCL20 transcription	50
SRSF10 promotes cisplatin resistance in bladder cancer via BIN1 Exon 12 retention and ANXA1 activation	50
PABPN1-C5 axis promotes hepatocellular carcinoma progression via NF-κB activation	50
Induction of IL6/STAT3-dependent TRAIL expression that contributes to the therapeutic efficacy of osimertinib in EGFR mutant NSCLC cells	49
Post-transcriptional control of gene expression by β-catenin: expanding the non-canonical ARMoury	48
The microbiome across the prostate disease continuum: from health and BPH to prostatitis/CPPS and cancer	48
Alternative splicing in prostate cancer progression and therapeutic resistance	48
NLRPs and tumor: research progress from molecular mechanisms to clinical applications	47
Pancreatic ductal adenocarcinoma induces neural injury that promotes a transcriptomic and functional repair signature by peripheral neuroglia	47
Chromatin-associated OGT promotes the malignant progression of hepatocellular carcinoma by activating ZNF263	47
Recent insights into the causes and consequences of chromosome mis-segregation	46
EGFR amplification and PI3K pathway mutations identify a subset of breast cancers that synergistically respond to EGFR and PI3K inhibition	46
Editorial Expression of Concern: Role of BRCA1 in heat shock response	46
AGO4 suppresses tumor growth by modulating autophagy and apoptosis via enhancing TRIM21-mediated ubiquitination of GRP78 in a p53-independent manner	45
Inhibition of multiple CDKs potentiates colon cancer chemotherapy via p73-mediated DR5 induction	45
Correction to: Ionizing radiation-induced NF-κB activation requires PARP-1 function to confer radioresistance	44
Correction: Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis	44
Correction: MZF1 mediates oncogene-induced senescence by promoting the transcription of p16INK4A	43
Correction: Editorial Expression of Concern: Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer	43
Correction: MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1	42
Correction: An FGFR-p53 developmental signaling axis drives salivary cancer progression	42
Single-cell multiomics reveals a gene regulatory circuit driving leukemia cell differentiation	42
Retraction Note: Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis	41
The lncRNA ST18-AS1 suppresses pancreatic cancer progression by enhancing ST18 mRNA stability through anchoring FUS in the cytoplasm	41
Delactylase effects of SIRT1 on a positive feedback loop involving the H19-glycolysis-histone lactylation in gastric cancer	40
The platelet pannexin 1-IL-1β axis orchestrates pancreatic ductal adenocarcinoma invasion and metastasis	40

CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype	40
ROS production by mitochondria: function or dysfunction?	40
Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis	40
Stabilization of MOF (KAT8) by USP10 promotes esophageal squamous cell carcinoma proliferation and metastasis through epigenetic activation of ANXA2/Wnt signaling	39
Correction: Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours	39
Engineering prostate cancer in vitro: what does it take?	39
Tumor cell-derived ANGPTL2 promotes β-catenin-driven intestinal tumorigenesis	38
Correction: NFκB activation by hypoxic small extracellular vesicles drives oncogenic reprogramming in a breast cancer microenvironment	38
YBX1 promotes 5-Fluorouracil resistance in gastric cancer via m5C-dependent ATG9A mRNA stabilization through autophagy	38
Correction: Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E	38
Functional screening reveals HORMAD1-driven gene dependencies associated with translesion synthesis and replication stress tolerance	38
Correction: ROR1-targeting switchable CAR-T cells for cancer therapy	38
PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer	37
SOX9 drives KRAS-induced lung adenocarcinoma progression and suppresses anti-tumor immunity	37
Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma	36
SIRT7: a novel molecular target for personalized cancer treatment?	36
METTL3 promotes cellular senescence of colorectal cancer via modulation of CDKN2B transcription and mRNA stability	36
Ac4C modification of lncRNA SIMALR promotes nasopharyngeal carcinoma progression through activating eEF1A2 to facilitate ITGB4/ITGA6 translation	36
Decitabine enhances targeting of AML cells by NY-ESO-1-specific TCR-T cells and promotes the maintenance of effector function and the memory phenotype	36
Tumor-mesothelium HOXA11-PDGF BB/TGF β1-miR-181a-5p-Egr1 feedforward amplifier circuity propels mesothelial fibrosis and peritoneal metastasis of gastric cancer	35
Feedback activation of EGFR/wild-type RAS signaling axis limits KRASG12D inhibitor efficacy in KRASG12D-mutated colorectal cancer	35
The sodium channel subunit SCNN1B suppresses colorectal cancer via suppression of active c-Raf and MAPK signaling cascade	35
BRD4 regulates PAI-1 expression in tumor-associated macrophages to drive chemoresistance in colorectal cancer	35
Hepatitis B virus X protein promotes the progression and immune escape of hepatocellular carcinoma by activating KLF16-C12orf49-PD-L1 axis	35
Enhanced anti-cancer efficacy of arginine deaminase expressed by tumor-seeking Salmonella Gallinarum	34
Cyclin E1 overexpression sensitizes ovarian cancer cells to WEE1 and PLK1 inhibition	34
E7-mediated repression of miR-203 promotes LASP1-dependent proliferation in HPV-positive cervical cancer	34
Activation of NFAT by HGF and IGF-1 via ARF6 and its effector ASAP1 promotes uveal melanoma metastasis	34
Mesenchymal stromal cells confer breast cancer doxorubicin resistance by producing hyaluronan	34
Decoding the adaptive survival mechanisms of breast cancer dormancy	33
Molecular insights into DDX3X–androgen receptor mRNA regulation via non-canonical G-quadruplex in castration-resistant prostate cancer	33
OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer	33
Molecular explorations of cancer biology and therapeutics at PDB-101	33
Therapeutic targeting the oncogenic driver EWSR1::FLI1 in Ewing sarcoma through inhibition of the FACT complex	33
The influence of endothelial metabolic reprogramming on the tumor microenvironment	33
C4orf19 inhibits colorectal cancer cell proliferation by competitively binding to Keap1 with TRIM25 via the USP17/Elk-1/CDK6 axis	33
Chronic stress drives gastric cancer lymph node metastasis via NETosis through a feedforward ACh-NGF axis-mediated PKC-γ/STAT3 pathway	33
Phosphorylation of USP27X by PIM2 promotes glycolysis and breast cancer progression via deubiquitylation of MYC	33
MicroRNAs: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances	33
CircVPS8 promotes the malignant phenotype and inhibits ferroptosis of glioma stem cells by acting as a scaffold for MKRN1, SOX15 and HNF4A	32
Correction: Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi’s sarcoma development	32
Correction to: Smad7 is inactivated through a direct physical interaction with the LIM protein Hic-5/ARA55	32
Correction: Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma	32
KDM1A-driven RNF81 downregulation promotes gastric cancer progression via KLF4 destabilization	32
Targeting SLP2-mediated lipid metabolism reprograming restricts proliferation and metastasis of hepatocellular carcinoma and promotes sensitivity to Lenvatinib	32
Correction: IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma	32
Shallow whole genome re-sequencing to precisely predict benefit from PARP inhibitor	32
Lysine metabolism is a novel metabolic tumor suppressor pathway in breast cancer	32
Dexamethasone promotes neutrophil ROS-mediated tumor killing through the glucocorticoid receptor	32
Correction: The ELF3-regulated lncRNA UBE2CP3 is over-stabilized by RNA–RNA interactions and drives gastric cancer metastasis via miR-138-5p/ITGA2 axis	32
Correction: Combination strategies with PARP inhibitors in BRCA-mutated triple-negative breast cancer: overcoming resistance mechanisms	31
Editorial Expression of Concern: Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress	31
Correction: Loss-of-function mutations of SOX17 lead to YAP/TEAD activation-dependent malignant transformation in endometrial cancer	31
Clustering single-cell RNA sequencing data via iterative smoothing and self-supervised discriminative embedding	31
The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a review	30
A proof of concept for targeting the PrPC - Amyloid β peptide interaction in basal prostate cancer and mesenchymal colon cancer	30
A multi-faceted discovery strategy identifies functional antibodies binding to cysteine-rich domain 1 of hDKK1 for cancer immunotherapy via Wnt non-canonical pathway	30
Editorial Expression of Concern: Gene expression profile by blocking the SYT-SSX fusion gene in synovial sarcoma cells. Identification of XRCC4 as a putative SYT-SSX target gene	30
ARHGAP–RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer	30
sEV-mediated intercellular transformation from MGAT4AHigh to MGAT4ALow tumor cells via the HOTAIRM1/miR-196b-5p axis promotes apoptosis resistance in CTCL	30
Celastrol recruits UBE3A to recognize and degrade the DNA binding domain of steroid receptors	30
Phosphorylation of FOXK2 at Thr13 and Ser30 by PDK2 sustains glycolysis through a positive feedback manner in ovarian cancer	29
O-GlcNAcylation of E3 ubiquitin ligase SKP2 promotes hepatocellular carcinoma proliferation	29
Retraction Note: Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor	29
circIPO7 dissociates caprin-1 from ribosomes and inhibits gastric cancer cell proliferation by suppressing EGFR and mTOR	29
Long non-coding RNA-MIR181A1HG acts as an oncogene and contributes to invasion and metastasis in gastric cancer	29
LncRNA PVT-1 promotes osteosarcoma cancer stem-like properties through direct interaction with TRIM28 and TSC2 ubiquitination	29
Retraction Note: Synergy between arsenic trioxide and JQ1 on autophagy in pancreatic cancer	29
The role of miR-92b-3p in notch signaling and monitoring of oral squamous cell carcinoma	29
Fusobacterium nucleatum drives colorectal cancer progression through the circPTBP3/miR-760/PUM1 axis	29
Leveraging RAS-mSIN1 interaction to selectively inhibit mTORC2 employing competitive RAS binding peptide: implications in breast cancer metastasis	29
Inactivation of kindlin-3 increases human melanoma aggressiveness through the collagen-activated tyrosine kinase receptor DDR1	29
The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulation	28
The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review	28
Trisomy 8 alters chromatin conformations and activates Y chromosome genes in stem cells to drive a pre-leukemic state	28
Comprehensive single-cell analysis reveals mast cells’ roles in cancer immunity	28
USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer	28
PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma	28
Zinc ions activate AKT and promote prostate cancer cell proliferation via disrupting AKT intramolecular interaction	28
Modelling adipose tissue-cancer crosstalk: a three-dimensional perspective	27

Selective inhibition of CDK9 in triple negative breast cancer	27
PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3	27
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer	27
MTPN drives noncanonical ERK hyperactivation in colorectal cancer and provides a promising therapeutic approach for precision medicine in CRC	27
The deubiquitinase OTUD1 orchestrates cisplatin chemosensitivity of non-small cell lung cancer through destabilizing RAD23B/XPC	27
Engineered targeting OIP5 sensitizes bladder cancer to chemotherapy resistance via TRIP12-PPP1CB-YBX1 axis	27
Single-cell landscape of undifferentiated pleomorphic sarcoma	27
HJURP is recruited to double-strand break sites and facilitates DNA repair by promoting chromatin reorganization	27
Targeting SREBP-dependent lipogenesis potentiates the anti-tumor activity of docetaxel by increasing membrane permeability and intracellular drug accumulation	27
JAK2/ULK1 axis promotes cervical cancer progression by autophagy induction and SRPK1 phosphorylation	26
Retraction Note: E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage	26
Correction: Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma	26
Retraction Note: Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer	26
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers	26
Correction: Lysine methyltransferase SMYD2 enhances androgen receptor signaling to modulate CRPC cell resistance to enzalutamide	26
Protein disulfide isomerase-enriched extracellular vesicles from bladder cancer cells support tumor survival and malignant transformation in the bladder	26
Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma	25
WTAP-mediated m6A methylation of PHF19 facilitates cell cycle progression by remodeling the accessible chromatin landscape in t(8;21) AML	25
A novel integrated approach to predicting cancer immunotherapy efficacy	25
Editorial Expression of Concern: Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer	25
RNF126-mediated ubiquitination of FSP1 affects its subcellular localization and ferroptosis	25
VprBP/DCAF1 regulates p53 function and stability through site-specific phosphorylation	25
GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma	25
Nuclear FGFR1 promotes pancreatic stellate cell-driven invasion through up-regulation of Neuregulin 1	25
Of travelling homeoproteins and medulloblastomas	25
Targeting FZD6 creates therapeutically actionable vulnerabilities for advanced prostate cancer	25
Pan-RAS inhibitors and polo-like kinase 1: promising targets in colorectal cancer	25
Correction: GALNT5 uaRNA promotes gastric cancer progression through its interaction with HSP90	25
Correction: Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma	25
ScRNA-seq of gastric cancer tissues reveals differences in the immune microenvironment of primary tumors and metastases	25
GNAO1 overexpression promotes neural differentiation of glioma stem-like cells and reduces tumorigenicity through TRIM21/CREB/HES1 axis	25
KRAS-extrachromosomal DNA drives intratumoral heterogeneity in gastric cancer	25
DMT1-dependent endosome-mitochondria interactions regulate mitochondrial iron translocation and metastatic outgrowth	24
NeuroD1 drives a KAT2A-FDFT1 signaling axis to promote cholesterol biosynthesis and hepatocellular carcinoma progression via histone H3K27 acetylation	24
Amyloid-like p53 as prognostic biomarker in serous ovarian cancer—a study of the OVCAD consortium	24
Ten years of oncogene editorship: a decade of transformation	24
BCL-2 isoform β promotes angiogenesis by TRiC-mediated upregulation of VEGF-A in lymphoma	24
ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis	24
ESR1 fusion proteins in breast cancer: distinguishing oncogenic drivers from passenger events	24
Importin-alpha transports Norrin to the nucleus to promote proliferation and Notch signaling in glioblastoma stem cells	24
A novel lncRNA MTAR1 promotes cancer development through IGF2BPs mediated post-transcriptional regulation of c-MYC	24
Ubiquitin and ubiquitin-like proteins in HPV-driven carcinogenesis	24
PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma	24
Correction: Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program	24
Retraction Note: miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer	24
Correction: Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma	24
M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription	24
Appearance of tuft cells during prostate cancer progression	24
The role of α-klotho in human cancer: molecular and clinical aspects	24
Origin and Evolution of RAS Membrane Targeting	24
Retraction Note: MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer	24
SMARCE1 promotes neuroblastoma tumorigenesis through assisting MYCN-mediated transcriptional activation	24
Circulating extracellular vesicles protein expression for early prediction of platinum-resistance in high-grade serous ovarian cancer	24
Editorial Expression of Concern: RING finger-dependent ubiquitination by PRAJA is dependent on TGF-ß and potentially defines the functional status of the tumor suppressor ELF	24
Neuropilin-2 promotes lineage plasticity and progression to neuroendocrine prostate cancer	24
GDP-mannose 4,6-dehydratase is a key driver of MYCN-amplified neuroblastoma core fucosylation and tumorigenesis	23
M7G modification of FTH1 and pri-miR-26a regulates ferroptosis and chemotherapy resistance in osteosarcoma	23
Persistent organic pollutants promote aggressiveness in prostate cancer	23
Correction: Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca2+/PI3K/AKT pathway	23
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer	23
p53 modulates kinase inhibitor resistance and lineage plasticity in NF1-related MPNSTs	23
Association of retinoids, retinoic acid receptors and epigenetics in breast cancer	23
EphA2 regulates vascular permeability and prostate cancer metastasis via modulation of cell junction protein phosphorylation	23
UBXN2A suppresses the Rictor-mTORC2 signaling pathway, an established tumorigenic pathway in human colorectal cancer	23
Arginine methylation-dependent stabilization of SUV39H1 promotes breast cancer growth	23
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis	23
JMJD6 in tumor-associated macrophage regulates macrophage polarization and cancer progression via STAT3/IL-10 axis	23
circSETD3 confers radiotherapy resistance in nasopharyngeal carcinoma by attenuating ER stress-induced autophagy and apoptosis via PDIA6 upregulation	23
Effect of TGF-β mediated phenotypic changes on prostate cancer cell anoikis response	22
Exosomal circSPIRE1 mediates glycosylation of E-cadherin to suppress metastasis of renal cell carcinoma	22
Epigenetics behind tumor immunology: a mini review	22
Correction: Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance	22
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer	22
CircUSP1 as a novel marker promotes gastric cancer progression via stabilizing HuR to upregulate USP1 and Vimentin	22
GPER-mediated stabilization of HIF-1α contributes to upregulated aerobic glycolysis in tamoxifen-resistant cells	22
HMGB1/SET/HAT1 complex-mediated SASH1 repression drives glycolysis and metastasis in lung adenocarcinoma	22
Cancer-associated fibroblasts promote EGFR-TKI resistance via the CTHRC1/glycolysis/H3K18la positive feedback loop	22
Targeting RBM39 suppresses tumor growth and sensitizes osteosarcoma cells to cisplatin	22
Rapid activation of ARF6 after RAF inhibition augments BRAFV600E and promotes therapy resistance	22
Nuclear translocation of Gasdermin D sensitizes colorectal cancer to chemotherapy in a pyroptosis-independent manner	22
Correction: Hsa_circ_0001361 promotes bladder cancer invasion and metastasis through miR-491-5p/MMP9 axis	22
Identification of a novel Calpain-2-SRC feed-back loop as necessity for β-Catenin accumulation and signaling activation in hepatocellular carcinoma	21
LIMK2 promotes centrosome clustering and cancer progression by activating MST4-mediated phosphorylation of NPM1	21
A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance	21
Salvage therapy with allogeneic invariant natural killer cells in a heavily pre-treated germ cell tumor	21
Altered gut microbiome composition by appendectomy contributes to colorectal cancer	21
SFXN1 promotes bladder cancer metastasis by restraining PINK1-dependent mitophagy	21
Circular RNA EIF3I promotes papillary thyroid cancer progression by interacting with AUF1 to increase Cyclin D1 production	21
EZH2 PROTACs target EZH2- and FOXM1-associated oncogenic nodes, suppressing breast cancer cell growth	21
TRIM59 is suppressed by androgen receptor and acts to promote lineage plasticity and treatment-induced neuroendocrine differentiation in prostate cancer	21
RNF187 neddylation in pancreatic cancer activates malignancy via IQGAP1-dependent actin cytoskeleton rearrangement	21
TMIGD1: Emerging functions of a tumor supressor and adhesion receptor	21
CRL2KLHDC3 and CRL1Fbxw7 cooperatively mediate c-Myc degradation	21
TWIST1 is a critical downstream target of the HGF/MET pathway and is required for MET driven acquired resistance in oncogene driven lung cancer	21
Blocking LBH expression causes replication stress and sensitizes triple-negative breast cancer cells to ATR inhibitor treatment	21